BETAHISTINE PRESCRIBING INFORMATION PDF

Author information Article notes Copyright and License information Disclaimer Betahistine dihydrochloride (Serc) is an oral preparation of a. PACKAGE LEAFLET: INFORMATION FOR THE USER. Betahistine Dihydrochloride 8 mg Tablets. Betahistine Dihydrochloride 16 mg Tablets prescription. Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière’s disease. It is also commonly Generic Prescription Products. Show.

Author: Magal Brakazahn
Country: Moldova, Republic of
Language: English (Spanish)
Genre: Business
Published (Last): 6 May 2006
Pages: 102
PDF File Size: 3.27 Mb
ePub File Size: 15.38 Mb
ISBN: 195-2-45893-661-3
Downloads: 62833
Price: Free* [*Free Regsitration Required]
Uploader: Kajijar

The therapeutic efficacy of Salbutamol can be decreased when used in combination with Betahistine. Ephedra The therapeutic efficacy of Ephedra can be decreased when used in combination with Betahistine. It would be safe to say that a current prevalence of 56 per in England would be an overestimate, as there is no evidence of a change in known aetiological factors and it would be more likely that some patients with recurrent vertigo in would nowadays be given an alternative diagnosis to Meniere’s disease due to our improved understanding of other conditions that present with recurrent vertigo.

Betahistine tablets are not recommended for use in children and adolescents below age 18 due to lack of data on safety and efficacy.

Formoterol The therapeutic efficacy of Formoterol can be decreased when used in combination with Betahistine.

Betahistine – DrugBank

The therapeutic efficacy of Betahistine can be decreased when used in betahistjne with Cinnarizine. The therapeutic efficacy of Betahistine can be decreased when used in combination with Aceprometazine. Cyclizine The therapeutic efficacy of Betahistine can be decreased when used in combination with Cyclizine.

  ALEXEI LEONTIEV PDF

Pirlindole The metabolism of Betahistine can be decreased when combined with Pirlindole. Carbinoxamine The therapeutic efficacy of Betahistine can be decreased when used in combination with Carbinoxamine.

The authors recommend that patients with symptoms of Meniere’s disease are appropriately managed bethistine an Otolaryngologist with an interest in Meniere’s disease and the initiation of a potentially life long treatment with Betahistine is given careful consideration. Therefore, the assessment of the pharmacokinetics of betahistine is based on the plasma concentration data of the only metabolite 2-pyridylacetic acid. The therapeutic efficacy of Betahistine can be decreased when used in combination with Benzquinamide.

The therapeutic efficacy of Protokylol can be decreased when used in combination with Betahistine. These can normally be dealt with by taking the dose during meals or by lowering the dose. Ebastine The therapeutic efficacy of Betahistine can be decreased when used in combination with Ebastine.

Prescribing practices for Betahistine

Mirtazapine The therapeutic efficacy of Betahistine can be decreased when used in combination with Mirtazapine. The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Betahistine.

The therapeutic efficacy of Betahistine can be decreased when used in combination with Famotidine. Pheniramine The therapeutic efficacy of Betahistine can be decreased when used in combination with Pheniramine. The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Betahistine. The therapeutic efficacy of Betahistine can be decreased when used in combination with Propiomazine.

  KRAMER SL 1996 GEOTECHNICAL EARTHQUAKE ENGINEERING PDF

Marketing authorisation number s 9. Hydracarbazine The metabolism of Betahistine can be decreased when combined with Hydracarbazine.

Benzylpenicilloyl Polylysine Betahistine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.

The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Prwscribing. Proc R Soc Med. Furazolidone The metabolism of Betahistine can be decreased when combined with Furazolidone. The therapeutic efficacy of Betahistine can be decreased when used in combination with Flunarizine.

Betahistine dihydrochloride Serc is an oral preparation of a histamine precursor marketed in Europe as a specific treatment for Meniere’s disease. Tripelennamine The therapeutic efficacy of Betahistine can be decreased when used in combination with Tripelennamine.

The therapeutic efficacy of Betahistine can be decreased when used in combination with Maprotiline. The therapeutic efficacy of Betahistine can be decreased when used in combination with Fexofenadine.

Following the absorption, the drug is metabolized rapidly in the infoormation and almost completely in metabolite 2-pyridylacetic acid. The invormation efficacy of Olodaterol can be decreased when used in combination with Betahistine. This explains the potent vasodilatory effects of betahistine in the inner ear. General Function Histamine receptor activity Specific Betahiztine In peripheral tissues, the H1 subclass of histamine receptors mediates the contraction of smooth muscles, increase in capillary permeability due to contraction of terminal venules, and catecholamin